Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors
Condition: Non-Seminomatous Germ Cell Tumor Interventions: Drug: BEP Protocol; Drug: Dose-dense regimen; Procedure: Early tumor resection or HD-CT Sponsor: Gustave Roussy, Cancer Campus, Grand Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2023 Category: Research Source Type: clinical trials